ABUS

Conviction 48HealthcareScan · Thu, Jun 25, 2026

ABUS$4.41-1.12%

ResistanceSupportVol 14

Vol MA14 2.59M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Arbutus Biopharma CorpPHARMACEUTICAL PREPARATIONSwww.arbutusbio.com ↗

Price4.41

Change-1.12%

Gap+0.45%

Rel volume3.66×

Avg volume2.24M

Avg $ vol9.89M

SMA 204.38

SMA 504.37

SMA 2004.42

Price vs 50+0.81%

Price vs 200-0.24%

MA stackmixed

50/200 cross—

Supertrendup · 4.12

RSI (14)51

MACD hist0.01

MACD crossbull · 5d

Stoch %K / %D48 / 52

ADX (14)16

+DI / −DI24 / 16

RSI divergence—

MACD divergence—

ATR %+4.10%

ADR %3.92%

52w high4.95

52w low3.09

From 52w high-10.91%

Above 52w low+42.72%

New 52w highNo

SqueezeOn · 1d

Bollinger width11.51%

%B0.57

Donchian pos48.02%

Donchian high4.79

Donchian low4.06

AVWAP (52w high)4.42

vs AVWAP high-0.13%

AVWAP (52w low)4.31

vs AVWAP low+2.21%

OBV trendDown

Chaikin MF (20)-0.10

Today vs 20d3.66×

Avg vol (14d)2.59M

Avg vol (20d)2.24M

Avg $ vol (20d)9.89M

Market cap871.14M

RS 3m (vs SPY)-8.78%

RS 6m (vs SPY)-7.06%

RS line new highNo

Trend template4/8

Technical rank37.8

1 week-0.45%

1 month-4.96%

3 months-2.65%

6 months-6.57%

1 year+30.86%

YTD-7.55%

P/E-26.00

P/B3.35

P/S61.86

P/FCF-21.98

EPS-0.1700

Div yield—

ROE-12.88%

ROA-12.09%

Debt/Eq0.00

Current54.26

EV/EBITDA—

Gross margin—

Net margin-237.88%

Rev growth128.21%

EPS growth52.09%

Price target—

Target upside—

Analyst rating—

Institutional75.03%

Ent. value847.44M

Revenue179.13M

Net income169.69M

Gross profit—

Free cash flow-39.64M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out197.54M

Employees19

ListedThu, Jul 26, 2007

Free float156.47M

Float %79.5%

Short interest16.98M

Days to cover9.2d

Short volume79.5%

Squeeze score82 / 100

Next earningsWed, Aug 5, 2026 (41d)

EPS forecast—

Last EPS vs est$0.87

Last surprise—

Setup gradeC

Conviction48 / 100

Pattern quality—

Tech rank37.8 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.79

Support4.06

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ABUS

All disclosures →

No recent disclosed trades by Congress in ABUS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ABUS · 2 buys

Insider	Side	Shares	Value	Traded	Filed
Sawhney Roger Director · Stock Option (Right to Buy) · 2026-06-08	Grant	78.8K	$0	2026-06-08	2026-06-10
Beardsley Robert A Director · Stock Option (Right to Buy) · 2026-06-08	Grant	78.8K	$0	2026-06-08	2026-06-10

SEC filings

EDGAR filings in ABUS

EDGAR →

No recent SEC filings on file for ABUS.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.